|
KIAA0922 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.055200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.244800E-01 |
| Normal-vs-Stage2 |
5.363200E-01 |
| Normal-vs-Stage3 |
3.472600E-01 |
| Normal-vs-Stage4 |
4.012400E-01 |
| Stage1-vs-Stage2 |
2.313600E-02 |
| Stage1-vs-Stage3 |
9.891800E-01 |
| Stage1-vs-Stage4 |
9.540400E-01 |
| Stage2-vs-Stage3 |
3.113600E-02 |
| Stage2-vs-Stage4 |
5.290200E-02 |
| Stage3-vs-Stage4 |
9.492400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.990830E-01 |
| Normal-vs-AfricanAmerican |
5.970800E-01 |
| Normal-vs-Asian |
4.572000E-01 |
| Caucasian-vs-AfricanAmerican |
6.548800E-01 |
| Caucasian-vs-Asian |
4.442800E-01 |
| AfricanAmerican-vs-Asian |
9.883600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.714000E-01 |
| Normal-vs-Female |
3.354000E-01 |
| Male-vs-Female |
2.913600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.915230E-01 |
| Normal-vs-Age(41-60Yrs) |
4.852800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.031200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.311200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.938780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.350400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.190600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.428400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.928200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.866600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.805900E-02 |
| Classical-VS-Follicular |
1.62458935193399E-12 |
| Classical-VS-Other |
1.249200E-01 |
| Classical-VS-Normal |
8.403600E-02 |
| Tall-VS-Follicular |
6.58669785380539E-11 |
| Tall-VS-Other |
4.474400E-02 |
| Tall-VS-Normal |
1.513690E-02 |
| Follicular-VS-Other |
1.863220E-01 |
| Follicular-VS-Normal |
1.503630E-02 |
| Other-VS-Normal |
7.791200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.796400E-01 |
| Normal-vs-N1 |
8.113800E-01 |
| N0-vs-N1 |
5.354800E-01 |
|
|
